These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of probenecid on dopamine metabolites of pigeon brain. Ahtee L; Sharman DF; Vogt M Br J Pharmacol; 1969 May; 36(1):202P-203P. PubMed ID: 5768112 [No Abstract] [Full Text] [Related]
24. Acceleration of the cerebral dopamine turnover by chlorpromazine. Da Prada M; Pletscher A Experientia; 1966 Jul; 22(7):465-6. PubMed ID: 5964107 [No Abstract] [Full Text] [Related]
25. Changes in mouse brain serotonin turnover following chronic imipramine administration. Hall TR; UrueƱa G; Figueroa HR Gen Pharmacol; 1985; 16(1):55-9. PubMed ID: 2579874 [TBL] [Abstract][Full Text] [Related]
26. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat. Uretsky NJ J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219 [No Abstract] [Full Text] [Related]
27. Homovanillic and 5-hydroxyindoleacetic acids in cerebrospinal fluid after probenecid: measurement of brain monoamine oxidase inhibition in vivo. Forn J; Maling HM; Gessa GL Proc Soc Exp Biol Med; 1970 Apr; 133(4):1310-3. PubMed ID: 5440420 [No Abstract] [Full Text] [Related]
28. Hypothalamic monoamine metabolism in mice: evaluation of drug challenges and neurotoxic insult. Dawson R; Callahan MF; Annau Z Pharmacology; 1986; 32(1):25-37. PubMed ID: 2418449 [TBL] [Abstract][Full Text] [Related]
29. Determination of homovanillic acid turnover in rat striatum using a monoamine oxidase inhibitor. Wiesel FA; Fri CG; Sedvall G Eur J Pharmacol; 1973 Jul; 23(1):104-6. PubMed ID: 4733765 [No Abstract] [Full Text] [Related]
30. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid. Andersson H; von Essen C; Roos BE Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033 [No Abstract] [Full Text] [Related]
31. Effect of oxygen on brain serotonin metabolism in rats. Diaz PM; Ngai SH; Costa E Am J Physiol; 1968 Mar; 214(3):591-4. PubMed ID: 5300205 [No Abstract] [Full Text] [Related]
32. Drugs and sleep. Oswald I Pharmacol Rev; 1968 Dec; 20(4):273-303. PubMed ID: 4305226 [No Abstract] [Full Text] [Related]
33. [Reversal of hypothermia in reserpine treated mice by neuro- and psycholeptic drugs]. Benz B; Waser PG Arzneimittelforschung; 1971 May; 21(5):654-61. PubMed ID: 4398310 [No Abstract] [Full Text] [Related]
34. On the mechanism of reversal of reserpine action by pargyline hydrochloride. Chopra YM; Dandiya PC Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):47-56. PubMed ID: 5350784 [No Abstract] [Full Text] [Related]
35. Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. Neef NH; Tozer TN; Brodie BB J Pharmacol Exp Ther; 1967 Nov; 158(2):214-8. PubMed ID: 6065144 [No Abstract] [Full Text] [Related]
36. Effect of lithium on brain 5-hydroxytryptamine metabolism in mice. Shaw JP; Ratcliffe F Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):116-24. PubMed ID: 136232 [TBL] [Abstract][Full Text] [Related]
37. Aggression in mice associated with changes in the monoamine metabolism of the brain. Lycke E; Modigh K; Roos BE Experientia; 1969 Sep; 25(9):951-3. PubMed ID: 5392704 [No Abstract] [Full Text] [Related]
38. Antagonism of morphine analgesia by reserpine and alpha-methyltyrosine and the role played by catecholamines in morphine analgesic action. Verri RA; Graeff FG; Corrado AP J Pharm Pharmacol; 1967 Apr; 19(4):264-5. PubMed ID: 4382313 [No Abstract] [Full Text] [Related]
39. The mechanism of action of anticonvulsants. I. Diphenylhydantoin. Rudzik AD; Mennear JH Life Sci; 1965 Dec; 4(24):2373-82. PubMed ID: 5879554 [No Abstract] [Full Text] [Related]
40. Pharmacological studies on antagonists against nicotine-induced convulsions and death. Yamamoto I; Otori K; Inoki R Jpn J Pharmacol; 1966 Dec; 16(4):402-15. PubMed ID: 4382719 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]